Please login to the form below

Not currently logged in
Email:
Password:

Roche's HIV-1 test approved in Europe

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test

Roche has announced that it has received CE Mark certification for its dual-target HIV-1 test.

This certification allows the product, which amplifies and detects two separate regions of the HIV-1 genome simultaneously, to be sold for clinical use in the European Union. According to the company, this provides reliable test results even when mutations are present.

"HIV mutations are a serious problem. Because it is impossible to predict when these mutations will occur, we have designed this test to detect all HIV-1 (Group M and O) strains," said Daniel O'Day, president and CEO of Roche Molecular Diagnostics. "This innovative fully-automated solution will provide reliable results for laboratories and physicians to more confidently and efficiently treat HIV-1 patients undergoing therapy."

HIV is a retrovirus that infects cells of the human immune system. In the early stages of infection, the person experiences no symptoms. Untreated, HIV will usually develop into AIDS within 10 to 15 years.

Roche's test is highly sensitive and can detect both very low and very high levels of the virus, a key indicator of the need for more or less aggressive treatment.
 

16th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics